LTI-01 + Placebo
Phase 2Completed 0 views this week 0 watching💤 Quiet
Interest: 25/100
25
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Pleural Effusion
Conditions
Pleural Effusion
Trial Timeline
Sep 26, 2020 → Jul 28, 2022
NCT ID
NCT04159831About LTI-01 + Placebo
LTI-01 + Placebo is a phase 2 stage product being developed by Rein Therapeutics for Pleural Effusion. The current trial status is completed. This product is registered under clinical trial identifier NCT04159831. Target conditions include Pleural Effusion.
What happened to similar drugs?
0 of 4 similar drugs in Pleural Effusion were approved
Approved (0) Terminated (0) Active (4)
Hype Score Breakdown
Clinical
12
Activity
8
Company
5
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04159831 | Phase 2 | Completed |
Competing Products
20 competing products in Pleural Effusion